Growth Hormone Deficiency (GHD) Treatment Market: Overview
The growth hormone deficiency (GHD) treatment market has made some notable strides on the back of the growing role of GH replacement therapy in managing GHD in adults. Advances in understanding clinical syndrome of GHD and understanding of diagnosis are key trends boosting the GHD treatment market. Clinical practices pertaining to pharmacological management of the syndrome in the GHD treatment market have made remarkable strides in the past five years. A growing body of epidemiological studies have focused on improving the safety, efficacy, and tolerability of GHD, especially in adults. Over the years, numerous benefits of GH replacement therapy have been recognized in mitigating the symptoms or reversing the conditions of this hormonal deficiency. Carniopharyngioma and pituitary adenoma are considered as the most potential causes of adult GHD per some international pharmaco-epidemiological surveillance database.
Some of the benefits of GH replacement therapy are positive impact on body composition, improvement in bone structure, some notable progress in health-related quality of life, and improvement in neuropsychiatric-cognitive, skeletal, and cardiovascular risk factors. Growing number of patients with chronic and severe GH deficiency who are made to undergo GH replacement therapy is a key trend underpinning the evolution of the GHD market.
Are you a start-up willing to tailored insights that will help you align operational and strategic goals in growth journey? Grab an exclusive PDF Brochure for this report!
Growth Hormone Deficiency (GHD) Treatment Market: Key Trends
Growing understanding of prevalence and incidence of adult-onset GH deficiency is a key trend boosting the GHD treatment market. Though exact prevalence are difficult to identify, but per a report by NCBI is ~2-3:10,000 population. In this regard, incidence of adult-onset GHD is a prominent factor. Growing number of studies in aetiology of hypopituitarism has expanded the avenue in the market.
The growing traction of GH hormone receptor polymorphism in the market has paved way to several new revenue streams for the healthcare and life sciences industries. However, childhood-onset isolated GH deficiency and chronic GHD pose considerable challenge for researchers looking to expand the avenue of GHD treatment market, as some studies have shed light on long-term effects on GH replacement therapy. A new avenue in the market has been opened by promise shown by pegylated human growth hormone. The growing mortality associated with hypopituitarism is a key trend boosting the demand for GHD treatment. Progress made in cardiovascular risk markers is also boosting the market.
Growth Hormone Deficiency (GHD) Treatment Market: Competitive Development Analysis and Key Developments
Companies are focused on developing GH dosing profile that are convenient to patient population. Focus is on developing high safety and tolerability in long-acting GH, especially for GHD in adults. Initial studies abound that pointed to risk of neoplasia in GHD. However, recent studies have pointed otherwise. Companies such as Pfizer revealed encouraging results. Moreover, prolonged-release GH is acting as a new avenue in the GHD treatment market. Aspiring players have conducted research on clinical presentations of GHD to document the benefits of adult GHD. Top players are leaning on expanding their product portfolio in recombinant human growth hormones. Some are focused on developing database in long-term GH replacement to consolidate their positions in the GHD treatment market.
Do you want to assess potential implications of COVID-19 pandemic on your business and boost your agility? Grab an exclusive Sample for this report!
Growth Hormone Deficiency (GHD) Treatment Market: Regional Assessment
On the regional front, North America and Europe are lucrative markets. Extensive research in clinical management of adult GHD has fueled opportunity generation in North America market. In recent years, GH replacement therapy has considerably changed the course of GHD treatment in Europe and North America. Asia Pacific is expected to be a promising regional market.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.